The possibility of hepatitis C reactivation in COVID-19 patients treated with corticosteroids.

Shokri, Somayeh; Mahmoudvand, Shahab

Shokri, Somayeh; Mahmoudvand, Shahab.

Shokri S; Department of Virology, School of Medicine, Hamadan University of Medical Science, Hamadan, Iran.
Mahmoudvand S; Department of Virology, School of Medicine, Hamadan University of Medical Science, Hamadan, Iran. Electronic address: mahmoudvandsh100@yahoo.com.

Ann Hepatol ; 27(4): 100704, 2022.

Article in English | MEDLINE | ID: covidwho-1773104

Subject(s)

COVID-19; Hepatitis C; Adrenal Cortex Hormones/adverse effects; Antiviral Agents/adverse effects; Hepacivirus/genetics; Hepatitis B Surface Antigens; Hepatitis B virus/physiology; Hepatitis C/diagnosis; Hepatitis C/drug therapy; Hepatitis C/epidemiology; Humans; Virus Activation

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hepatitis C / COVID-19 Type of study: Diagnostic study / Observational study Limits: Humans Language: English Journal: Ann Hepatol Journal subject: Gastroenterology Year: 2022 Document Type: Article Affiliation country: J.aohep.2022.100704

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google